Detailansicht

Wissensnetz

Person

Denisa Bojkova (1991-)

Biologin

Name	Denisa Bojkova
Zeit	1991- (Lebensdaten)
Ort	Bojnice (Geburtsort) Slowakei
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Dr. rer. nat.
Beruf	Biologin (charakteristischer Beruf)
Beziehung	Universität Duisburg-Essen. Fakultät für Biologie
Quelle	Bojkova, Denisa: Development of antiviral strategies against positive-sense single stranded RNA viruses
Datensatztyp	Person
GND-Nummer	1222679833
Datensatz-ID	1222679833
Beteiligt an alle anzeigen Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro Construction and characterization of a high-capacity replication-competent murine cytomegalovirus vector for gene delivery The role of soluble epoxide hydrolase in macrophage and astrocyte polarization Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform Identification of Z-Tyr-Ala-CHN2, a cathepsin L inhibitor with broad-spectrum cell-specific activity against coronaviruses, including SARS-CoV-2 Repurposing of the antibiotic nitroxoline for the treatment of mpox SARS-CoV-2 variants show different host cell proteome profiles with delayed immune response activation in Omicron-infected cells USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING Development and optimisation of a high-throughput screening assay for in vitro antiSARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform Impact of the COVID-19 pandemic on the circulation of other pathogens in England Omicron-induced interferon signalling prevents influenza A virus infection Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates Repurposing of the antibiotic nitroxoline for the treatment of mpox SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings A potential role of the CD47/SIRPalpha axis in COVID-19 pathogenesis Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies CD47 as a potential biomarker for the early diagnosis of severe COVID-19 Characterization of ACE inhibitors and AT1R antagonists with regard to their effect on ACE2 expression and infection with SARS-CoV-2 using a Caco-2 cell model Enisamium inhibits SARS-CoV-2 RNA synthesis Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings In vitro activity of itraconazole against SARS-CoV-2 Infectivity of deceased COVID-19 patients Targeting the pentose phosphate pathway for SARS-CoV-2 therapy The COVID-19 PHARMACOME: a method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization Aprotinin inhibits SARS-CoV-2 replication Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies COVID-19-related coagulopathy - is transferrin a missing link? COVID-19-related coagulopathy - is transferrin a missing link? Development of antiviral strategies against positive-sense single stranded RNA viruses Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles Targeting pentose phosphate pathway for SARS-CoV-2 therapy

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Denisa Bojkova (1991-)

Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro

Construction and characterization of a high-capacity replication-competent murine cytomegalovirus vector for gene delivery

The role of soluble epoxide hydrolase in macrophage and astrocyte polarization

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform

Identification of Z-Tyr-Ala-CHN2, a cathepsin L inhibitor with broad-spectrum cell-specific activity against coronaviruses, including SARS-CoV-2

Repurposing of the antibiotic nitroxoline for the treatment of mpox

SARS-CoV-2 variants show different host cell proteome profiles with delayed immune response activation in Omicron-infected cells

USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING

Development and optimisation of a high-throughput screening assay for in vitro antiSARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures

Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform

Impact of the COVID-19 pandemic on the circulation of other pathogens in England

Omicron-induced interferon signalling prevents influenza A virus infection

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Repurposing of the antibiotic nitroxoline for the treatment of mpox

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment

SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings

A potential role of the CD47/SIRPalpha axis in COVID-19 pathogenesis

Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies

CD47 as a potential biomarker for the early diagnosis of severe COVID-19

Characterization of ACE inhibitors and AT1R antagonists with regard to their effect on ACE2 expression and infection with SARS-CoV-2 using a Caco-2 cell model

Enisamium inhibits SARS-CoV-2 RNA synthesis

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings

In vitro activity of itraconazole against SARS-CoV-2

Infectivity of deceased COVID-19 patients

Targeting the pentose phosphate pathway for SARS-CoV-2 therapy

The COVID-19 PHARMACOME: a method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization

Aprotinin inhibits SARS-CoV-2 replication

Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies

COVID-19-related coagulopathy - is transferrin a missing link?

COVID-19-related coagulopathy - is transferrin a missing link?

Development of antiviral strategies against positive-sense single stranded RNA viruses

Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication

Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

Targeting pentose phosphate pathway for SARS-CoV-2 therapy